Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
OGI
HoldUnloved QualityOrganigram Global Inc. · Healthcare · Canada · $171M · Avg Vol: $2M/d
COMPANY DESCRIPTION
Organigram Global Inc. (operating as Organigram Holdings) is a licensed producer of medical cannabis and cannabis-derived products, focusing on both the recreational and medical markets in Canada and internationally. The company differentiates itself through its indoor cultivation expertise, product innovation, and expanding distribution network, aiming to capture market share in the evolving cannabis industry.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 57.3M | 105.6M | 115.7M | 187.7M | 34.5% | 224.0M | 253.2M | 331.7M | 32.9% |
| EPS | -1.48 | -0.13 | -0.35 | -0.14 | — | 0.43 | — | — | — |
| Shares | 74.7M | 78.5M | 108.6M | 134.5M | +80.0% | 144.2M | — | — | — |
| Debt | 4.3M | 2.4M | 3.2M | 6.3M | 10.2% | 15.2M | — | — | — |
| Equity | 347.4M | 367.8M | 221.5M | 252.8M | -7.6% | — | — | — | — |
| Op CF | -20.7M | -26.2M | 2.8M | -5.5M | — | -20.7M | — | — | — |
| Inv CF | -83.3M | 31.9M | -22.3M | -58.7M | — | — | — | — | — |
| Fin CF | 126.3M | 3.9M | 78.0M | 28.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OGI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OGI | Organigram Global Inc.(you) | $171M | 64 | Hold |
| TSND.TO | TerrAscend Corp. | $243M | 61 | Hold |
| HLS.TO | HLS Therapeutics Inc. | $80M | 67 | Buy |
| DB.V | Decibel Cannabis Company Inc. | $51M | 67 | Buy |
| ACB.TO | Aurora Cannabis Inc. | $253M | 40 | Hold |
| RX.V | BioSyent Inc. | $130M | 92 | Strong Buy |
| MDP.TO | Medexus Pharmaceuticals Inc. | $118M | 90 | Strong Buy |
| LOVE.TO | Cannara Biotech Inc. | $141M | 95 | Strong Buy |
| CPH.TO | Cipher Pharmaceuticals Inc. | $265M | 93 | Strong Buy |
| XLY.TO | Auxly Cannabis Group Inc. | $232M | 98 | Strong Buy |
Peer medians: ROE -37.9% · P/E 18.1x · Gross margin 46.2%